288 related articles for article (PubMed ID: 21930885)
1. Comparative performances of flubendazole and albendazole in cystic echinococcosis: ex vivo activity, plasma/cyst disposition, and efficacy in infected mice.
Ceballos L; Elissondo C; Sánchez Bruni S; Denegri G; Lanusse C; Alvarez L
Antimicrob Agents Chemother; 2011 Dec; 55(12):5861-7. PubMed ID: 21930885
[TBL] [Abstract][Full Text] [Related]
2. A pharmacology-based comparison of the activity of albendazole and flubendazole against Echinococcus granulosus metacestode in sheep.
Ceballos L; Virkel G; Elissondo C; Canton C; Canevari J; Murno G; Denegri G; Lanusse C; Alvarez L
Acta Trop; 2013 Sep; 127(3):216-25. PubMed ID: 23692888
[TBL] [Abstract][Full Text] [Related]
3. Combined flubendazole-nitazoxanide treatment of cystic echinococcosis: Pharmacokinetic and efficacy assessment in mice.
Laura C; Celina E; Sergio SB; Guillermo D; Carlos L; Luis A
Acta Trop; 2015 Aug; 148():89-96. PubMed ID: 25917712
[TBL] [Abstract][Full Text] [Related]
4. Efficiency of flubendazole-loaded mPEG-PCL nanoparticles: A promising formulation against the protoscoleces and cysts of Echinococcus granulosus.
Farhadi M; Haniloo A; Rostamizadeh K; Faghihzadeh S
Acta Trop; 2018 Nov; 187():190-200. PubMed ID: 30098942
[TBL] [Abstract][Full Text] [Related]
5. Albendazole-lipid nanocapsules: Optimization, characterization and chemoprophylactic efficacy in mice infected with Echinococcus granulosus.
Ullio Gamboa GV; Pensel PE; Elissondo MC; Sanchez Bruni SF; Benoit JP; Palma SD; Allemandi DA
Exp Parasitol; 2019 Mar; 198():79-86. PubMed ID: 30769018
[TBL] [Abstract][Full Text] [Related]
6. Flubendazole in cystic echinococcosis therapy: pharmaco-parasitological evaluation in mice.
Ceballos L; Elissondo M; Bruni SS; Denegri G; Alvarez L; Lanusse C
Parasitol Int; 2009 Dec; 58(4):354-8. PubMed ID: 19628054
[TBL] [Abstract][Full Text] [Related]
7. Albendazole treatment in cystic echinococcosis: pharmacokinetics and clinical efficacy of two different aqueous formulations.
Ceballos L; Elissondo C; Moreno L; Dopchiz M; Sánchez Bruni S; Denegri G; Alvarez L; Lanusse C
Parasitol Res; 2008 Jul; 103(2):355-62. PubMed ID: 18465143
[TBL] [Abstract][Full Text] [Related]
8. Experimental cystic echinococcosis therapy: In vitro and in vivo combined 5-fluorouracil/albendazole treatment.
Pensel PE; Elissondo N; Gambino G; Gamboa GU; Benoit JP; Elissondo MC
Vet Parasitol; 2017 Oct; 245():62-70. PubMed ID: 28969840
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo efficacies of novel carbazole aminoalcohols in the treatment of cystic echinococcosis.
Wang W; Li J; Yao J; Wang T; Li S; Zheng X; Duan L; Zhang W
J Antimicrob Chemother; 2017 Nov; 72(11):3122-3130. PubMed ID: 28981899
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo effects of flubendazole on Echinococcus granulosus metacestodes.
Elissondo M; Ceballos L; Dopchiz M; Andresiuk V; Alvarez L; Bruni SS; Lanusse C; Denegri G
Parasitol Res; 2007 Apr; 100(5):1003-9. PubMed ID: 17171566
[TBL] [Abstract][Full Text] [Related]
11. Cystic echinococcosis therapy: Albendazole-loaded lipid nanocapsules enhance the oral bioavailability and efficacy in experimentally infected mice.
Pensel PE; Ullio Gamboa G; Fabbri J; Ceballos L; Sanchez Bruni S; Alvarez LI; Allemandi D; Benoit JP; Palma SD; Elissondo MC
Acta Trop; 2015 Dec; 152():185-194. PubMed ID: 26409727
[TBL] [Abstract][Full Text] [Related]
12. In vivo evaluation of the efficacy of combined albedazole-IFN-α treatment for cystic echinococcosis in mice.
Zhang S; Zhou Y; Su L; Zhang X; Wang H; Liu B
Parasitol Res; 2017 Feb; 116(2):735-742. PubMed ID: 27928681
[TBL] [Abstract][Full Text] [Related]
13. In vivo evaluation of the efficacy of albendazole sulfoxide and albendazole sulfoxide loaded solid lipid nanoparticles against hydatid cyst.
Ahmadnia S; Moazeni M; Mohammadi-Samani S; Oryan A
Exp Parasitol; 2013 Oct; 135(2):314-9. PubMed ID: 23912040
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of novel albendazole salt formulations against secondary cystic echinococcosis in experimentally infected mice.
Vural G; Yardimci M; Kocak M; Yasar TÖ; Kurt A; Harem IS; Carradori S; Sciamanna I; Siles-Lucas M; Fabiani M; Hemphill A; Lundström-Stadelmann B; Cirilli R; Casulli A
Parasitology; 2020 Nov; 147(13):1425-1432. PubMed ID: 32729453
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of albendazole chitosan microspheres against Echinococcus granulosus infection in mice].
Liang W; Wang XC; Wu XW; Zhang SJ; Sun H; Ma X; Peng XY
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2014 Jun; 32(3):188-92. PubMed ID: 25223052
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of albendazole-loaded nanostructured lipid carriers on Echinococcus granulosus microcysts and their prophylactic efficacy on experimental secondary hydatidosis.
Farhadi M; Haniloo A; Rostamizadeh K; Ahmadi N
Parasitol Res; 2021 Dec; 120(12):4049-4060. PubMed ID: 34669034
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the efficacy of albendazole sulfoxide (ABZ-SO)-loaded chitosan-PLGA nanoparticles in the treatment of cystic echinococcosis in laboratory mice.
Darvishi MM; Moazeni M; Alizadeh M; Abedi M; Tamaddon AM
Parasitol Res; 2020 Dec; 119(12):4233-4241. PubMed ID: 32996050
[TBL] [Abstract][Full Text] [Related]
18. Flubendazole and ivermectin in vitro combination therapy produces a marked effect on Echinococcus granulosus protoscoleces and metacestodes.
Elissondo MC; Ceballos L; Alvarez L; Sánchez Bruni S; Lanusse C; Denegri G
Parasitol Res; 2009 Sep; 105(3):835-42. PubMed ID: 19444468
[TBL] [Abstract][Full Text] [Related]
19. Intra-cystic concentrations of albendazole-sulphoxide in human cystic echinococcosis: a systematic review and analysis of individual patient data.
Lötsch F; Naderer J; Skuhala T; Groger M; Auer H; Kaczirek K; Waneck F; Ramharter M
Parasitol Res; 2016 Aug; 115(8):2995-3001. PubMed ID: 27085708
[TBL] [Abstract][Full Text] [Related]
20. Integrated pharmacological assessment of flubendazole potential for use in sheep: disposition kinetics, liver metabolism and parasite diffusion ability.
Moreno L; Alvarez L; Mottier L; Virkel G; Bruni SS; Lanusse C
J Vet Pharmacol Ther; 2004 Oct; 27(5):299-308. PubMed ID: 15500567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
